Catalyst Wire Dossier Catalyst Wire Dossier

HIV-1 Trimer 6931 Vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV-1 Trimer 6931 Vaccine, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults [Phase 1]

See pricing